Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program

NAActive, not recruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2026

Conditions
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Interventions
OTHER

Multiple Myeloma M-Protein Analysis

Participants will be screened with a blood test for monoclonal protein analysis

OTHER

Multiple Myeloma Knowledge Questionnaires

Participants will complete two questionnaires to share their attitudes toward their screening experience and completion of knowledge questions to gauge community reception and participant multiple myeloma knowledge.

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER